Hypoxic Preconditioned Nanofat at 1% O₂ for 24 h Loses Its Regenerative In Vivo Vascularization Capacity

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Vascular Biology

Background:

• Fat grafting is crucial for tissue regeneration.
• Enhancing fat graft survival and vascularization is a key challenge.
• Hypoxic preconditioning is explored to improve fat graft outcomes.

Purpose of the Study:

• To investigate the effects of severe hypoxic preconditioning (1% O2, 24h) on nanofat.
• To assess nanofat viability, gene expression, and in vivo vascularization capacity.
• To determine if this protocol enhances fat graft regeneration.

Main Methods:

• Nanofat was subjected to hypoxic preconditioning (1% O2, 24h) or normoxia.
• Ex vivo analysis included cell death assays and gene/protein expression profiling (HIF-1α, SDF-1).
• In vivo assessment involved seeding dermal substitutes with nanofat, implantation into mouse dorsal skinfold chambers, and intravital fluorescence microscopy for vascularization.

Main Results:

• Hypoxic preconditioning did not alter apoptotic or necrotic cell death in nanofat.
• Significant upregulation of hypoxia-inducible factor (HIF)-1α and stromal cell-derived factor (SDF)-1 was observed.
• Contrary to expectations, preconditioned nanofat implants showed significantly reduced functional microvessel density in vivo.
• Immunohistochemistry confirmed lower microvessel density in the hypoxic group.

Conclusions:

• Severe hypoxic preconditioning (1% O2, 24h) is not recommended for enhancing nanofat vascularization.
• The protocol failed to improve in vivo regenerative capacity and unexpectedly reduced vascularization.
• Future studies should explore milder hypoxic conditions (higher O2 levels or shorter durations).